 | 51T | 表記: | 2,3,6-trifluoro-L-tyrosine | 組成式: | C9 H8 F3 N O3 | SMILES: | NC(Cc1c(cc(c(c1F)F)O)F)C(=O)O | InChi: | InChI=1S/C9H8F3NO3/c10-4-2-6(14)8(12)7(11)3(4)1-5(13)9(15)16/h2,5,14H,1,13H2,(H,15,16)/t5-/m0/s1 | 定義日: | 2015-07-13 | 最終更新日: | 2024-09-27 | 公開日: | 2016-06-22 | 識別子(ID): | 2,3,6-trifluoro-L-tyrosine |
|
 | N36 | 表記: | 3-ethoxy-4-hydroxybenzaldehyde | 組成式: | C9 H10 O3 | SMILES: | CCOc1cc(ccc1O)C=O | InChi: | InChI=1S/C9H10O3/c1-2-12-9-5-7(6-10)3-4-8(9)11/h3-6,11H,2H2,1H3 | 別名: | Ethyl vanillin | 定義日: | 2022-03-23 | 最終更新日: | 2024-09-27 | 公開日: | 2022-12-14 | 識別子(ID): | 3-ethoxy-4-hydroxybenzaldehyde |
|
 | N38 | 表記: | 3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-{[3-(4-methoxyphenoxy)propyl]sulfonyl}-L-
alaninamide | 組成式: | C26 H41 N3 O7 S | SMILES: | COc3ccc(OCCCS(NC(CC1CCCCC1)C(NC(CO)CC2CCNC2=O)=O)(=O)=O)cc3 | InChi: | InChI=1S/C26H41N3O7S/c1-35-22-8-10-23(11-9-22)36-14-5-15-37(33,34)29-24(16-19-6-3-2-4-7-19)26(32)28-21(18-30)17-20-12-13-27-25(20)31/h8-11,19-21,24,29-30H,2-7,12-18H2,1H3,(H,27,31)(H,28,32)/t20-,21-,24-/m0/s1 | 別名: | 3-cyclohexyl-N~2~-{[3-(4-methoxyphenoxy)propyl]sulfonyl}-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alan
inamide (bound form) | 定義日: | 2016-09-12 | 最終更新日: | 2024-09-27 | 公開日: | 2016-11-23 | 識別子(ID): | 3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-{[3-(4-methoxyphenoxy)propyl]sulfonyl}-L-alaninamide |
|
 | 523 | 表記: | 2'-DEOXY-5-METHYLCYTIDINE 5'-(TETRAHYDROGEN TRIPHOSPHATE) | 組成式: | C10 H19 N3 O13 P3 | SMILES: | O=P(O)(O)OP(=O)(O)OP(=O)(O)OCC2OC([N+]=1C(=O)NC(N)=C(C=1)C)CC2O | InChi: | InChI=1S/C10H18N3O13P3/c1-5-3-13(10(15)12-9(5)11)8-2-6(14)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18/h3,6-8,14H,2,4H2,1H3,(H6,11,12,15,16,17,18,19,20,21,22)/p+1/t6-,7+,8+/m0/s1 | 別名: | 5-METHYL-2'-DEOXY-CYTIDINE-5'-TRIPHOSPHATE | 定義日: | 2007-01-22 | 最終更新日: | 2024-09-27 | 識別子(ID): | 2'-deoxy-5-methylcytidine 5'-(tetrahydrogen triphosphate) |
|
 | N3O | 表記: | ~{N}-(3-methyl-[1,2]oxazolo[5,4-b]pyridin-5-yl)propanamide | 組成式: | C10 H11 N3 O2 | SMILES: | CCC(=O)Nc1cnc2onc(C)c2c1 | InChi: | InChI=1S/C10H11N3O2/c1-3-9(14)12-7-4-8-6(2)13-15-10(8)11-5-7/h4-5H,3H2,1-2H3,(H,12,14) | 定義日: | 2022-08-11 | 最終更新日: | 2024-09-27 | 公開日: | 2022-09-28 | 識別子(ID): | ~{N}-(3-methyl-[1,2]oxazolo[5,4-b]pyridin-5-yl)propanamide |
|
 | N3X | 表記: | ~{N}-[(1-methylindazol-6-yl)methyl]propanamide | 組成式: | C12 H15 N3 O | SMILES: | CCC(=O)NCc1ccc2cnn(C)c2c1 | InChi: | InChI=1S/C12H15N3O/c1-3-12(16)13-7-9-4-5-10-8-14-15(2)11(10)6-9/h4-6,8H,3,7H2,1-2H3,(H,13,16) | 定義日: | 2022-08-11 | 最終更新日: | 2024-09-27 | 公開日: | 2022-09-28 | 識別子(ID): | ~{N}-[(1-methylindazol-6-yl)methyl]propanamide |
|
 | N40 | 表記: | 3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-(octylsulfonyl)-L-alaninamide | 組成式: | C24 H45 N3 O5 S | SMILES: | C(CCCCCCC)S(NC(CC1CCCCC1)C(NC(CO)CC2CCNC2=O)=O)(=O)=O | InChi: | InChI=1S/C24H45N3O5S/c1-2-3-4-5-6-10-15-33(31,32)27-22(16-19-11-8-7-9-12-19)24(30)26-21(18-28)17-20-13-14-25-23(20)29/h19-22,27-28H,2-18H2,1H3,(H,25,29)(H,26,30)/t20-,21-,22-/m0/s1 | 別名: | 3-cyclohexyl-N~2~-(octylsulfonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide (bound form) | 定義日: | 2016-09-12 | 最終更新日: | 2024-09-27 | 公開日: | 2016-11-23 | 識別子(ID): | 3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-(octylsulfonyl)-L-alaninamide |
|
 | N42 | 表記: | N-[3-(5-{[3-(acryloylamino)-4-(morpholine-4-carbonyl)phenyl]amino}-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl]-4-tert-butylbenzamide | 組成式: | C38 H41 N5 O5 | SMILES: | C=[C@H]C(=O)Nc2c(C(=O)N1CCOCC1)ccc(c2)NC3=CC(=CN(C3=O)C)c4cccc(c4C)NC(=O)c5ccc(cc5)C(C)(C)C | InChi: | InChI=1S/C38H41N5O5/c1-7-34(44)40-32-22-28(15-16-30(32)36(46)43-17-19-48-20-18-43)39-33-21-26(23-42(6)37(33)47)29-9-8-10-31(24(29)2)41-35(45)25-11-13-27(14-12-25)38(3,4)5/h7-16,21-23,39H,1,17-20H2,2-6H3,(H,40,44)(H,41,45) | 定義日: | 2016-04-20 | 最終更新日: | 2024-09-27 | 公開日: | 2017-04-19 | 識別子(ID): | N-[3-(5-{[3-(acryloylamino)-4-(morpholine-4-carbonyl)phenyl]amino}-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl]-4-tert-butylbenzamide |
|
 | 52T | 表記: | (4R,7R)-7-hydroxy-1-(4-methoxybenzyl)-7-methyl-4,5,6,7-tetrahydro-1H-benzotriazol-4-yl propan-2-ylcarbamate | 組成式: | C19 H26 N4 O4 | SMILES: | C(n2c1c(C(OC(NC(C)C)=O)CCC1(O)C)nn2)c3ccc(cc3)OC | InChi: | InChI=1S/C19H26N4O4/c1-12(2)20-18(24)27-15-9-10-19(3,25)17-16(15)21-22-23(17)11-13-5-7-14(26-4)8-6-13/h5-8,12,15,25H,9-11H2,1-4H3,(H,20,24)/t15-,19-/m1/s1 | 定義日: | 2015-07-20 | 最終更新日: | 2024-09-27 | 公開日: | 2016-01-13 | 識別子(ID): | (4R,7R)-7-hydroxy-1-(4-methoxybenzyl)-7-methyl-4,5,6,7-tetrahydro-1H-benzotriazol-4-yl propan-2-ylcarbamate |
|
 | N4F | 表記: | 1-(6,7-dihydro-4~{H}-[1,3]thiazolo[5,4-c]pyridin-5-yl)propan-1-one | 組成式: | C9 H12 N2 O S | SMILES: | CCC(=O)N1CCc2ncsc2C1 | InChi: | InChI=1S/C9H12N2OS/c1-2-9(12)11-4-3-7-8(5-11)13-6-10-7/h6H,2-5H2,1H3 | 定義日: | 2022-08-11 | 最終更新日: | 2024-09-27 | 公開日: | 2022-09-28 | 識別子(ID): | 1-(6,7-dihydro-4~{H}-[1,3]thiazolo[5,4-c]pyridin-5-yl)propan-1-one |
|
 | N4U | 表記: | ~{N}-(2-methylpyrimidin-5-yl)propanamide | 組成式: | C8 H11 N3 O | SMILES: | CCC(=O)Nc1cnc(C)nc1 | InChi: | InChI=1S/C8H11N3O/c1-3-8(12)11-7-4-9-6(2)10-5-7/h4-5H,3H2,1-2H3,(H,11,12) | 定義日: | 2022-08-12 | 最終更新日: | 2024-09-27 | 公開日: | 2022-09-28 | 識別子(ID): | ~{N}-(2-methylpyrimidin-5-yl)propanamide |
|
 | 54C | 表記: | (betaR)-beta-hydroxy-1-{2-[(2R)-oxiran-2-yl]propan-2-yl}-L-tryptophan | 組成式: | C16 H20 N2 O4 | SMILES: | C(C(=O)O)(N)C(c1cn(c2c1cccc2)C(C)(C)C3CO3)O | InChi: | InChI=1S/C16H20N2O4/c1-16(2,12-8-22-12)18-7-10(14(19)13(17)15(20)21)9-5-3-4-6-11(9)18/h3-7,12-14,19H,8,17H2,1-2H3,(H,20,21)/t12-,13-,14+/m0/s1 | 定義日: | 2015-07-23 | 最終更新日: | 2024-09-27 | 公開日: | 2015-10-28 | 識別子(ID): | (betaR)-beta-hydroxy-1-{2-[(2R)-oxiran-2-yl]propan-2-yl}-L-tryptophan |
|
 | N5U | 表記: | 1-[(2~{R})-2-(3-methylimidazol-4-yl)piperidin-1-yl]propan-1-one | 組成式: | C12 H19 N3 O | SMILES: | CCC(=O)N1CCCC[CH]1c2cncn2C | InChi: | InChI=1S/C12H19N3O/c1-3-12(16)15-7-5-4-6-10(15)11-8-13-9-14(11)2/h8-10H,3-7H2,1-2H3/t10-/m1/s1 | 定義日: | 2022-08-12 | 最終更新日: | 2024-09-27 | 公開日: | 2022-09-28 | 識別子(ID): | 1-[(2~{R})-2-(3-methylimidazol-4-yl)piperidin-1-yl]propan-1-one |
|
 | 54G | 表記: | 2-hydroxy-5-methylbenzoic acid | 組成式: | C8 H8 O3 | SMILES: | c1cc(c(cc1C)C(O)=O)O | InChi: | InChI=1S/C8H8O3/c1-5-2-3-7(9)6(4-5)8(10)11/h2-4,9H,1H3,(H,10,11) | 定義日: | 2015-07-23 | 最終更新日: | 2024-09-27 | 公開日: | 2016-07-27 | 識別子(ID): | 2-hydroxy-5-methylbenzoic acid |
|
 | 54I | 表記: | (3E)-3-(hydroxyimino)propanoic acid | 組成式: | C3 H5 N O3 | SMILES: | O=C(O)CC=NO | InChi: | InChI=1S/C3H5NO3/c5-3(6)1-2-4-7/h2,7H,1H2,(H,5,6)/b4-2+ | 定義日: | 2021-07-15 | 最終更新日: | 2024-09-27 | 公開日: | 2021-12-01 | 識別子(ID): | (3E)-3-(hydroxyimino)propanoic acid |
|
 | 54L | 表記: | pent-4-ynoic acid | 組成式: | C5 H6 O2 | SMILES: | C(CCC#C)(=O)O | InChi: | InChI=1S/C5H6O2/c1-2-3-4-5(6)7/h1H,3-4H2,(H,6,7) | 定義日: | 2015-07-23 | 最終更新日: | 2024-09-27 | 公開日: | 2015-12-02 | 識別子(ID): | pent-4-ynoic acid |
|
 | N63 | 表記: | (1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[3-(trifluoromethyl)phenyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid | 組成式: | C22 H30 F3 N3 O8 S | SMILES: | FC(F)(F)c1cccc(c1)COC(=O)NC(CC(C)C)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | InChi: | InChI=1S/C22H30F3N3O8S/c1-12(2)8-16(28-21(32)36-11-13-4-3-5-15(9-13)22(23,24)25)19(30)27-17(20(31)37(33,34)35)10-14-6-7-26-18(14)29/h3-5,9,12,14,16-17,20,31H,6-8,10-11H2,1-2H3,(H,26,29)(H,27,30)(H,28,32)(H,33,34,35)/t14-,16-,17-,20?/m0/s1 | 定義日: | 2022-01-19 | 最終更新日: | 2024-09-27 | 公開日: | 2022-05-04 | 識別子(ID): | (1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[3-(trifluoromethyl)phenyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid |
|
 | N65 | 表記: | (2~{S})-2-azanyl-6-[(~{E})-pentan-2-ylideneamino]hexanal | 組成式: | C11 H22 N2 O2 | SMILES: | CCCC(C)=NCCCC[CH](N)C(O)=O | InChi: | InChI=1S/C11H22N2O2/c1-3-6-9(2)13-8-5-4-7-10(12)11(14)15/h10H,3-8,12H2,1-2H3,(H,14,15)/b13-9+/t10-/m0/s1 | 定義日: | 2019-11-13 | 最終更新日: | 2024-09-27 | 公開日: | 2020-06-03 | 識別子(ID): | (2~{S})-2-azanyl-6-[(~{E})-pentan-2-ylideneamino]hexanoic acid |
|
 | N6K | 表記: | ~{N}-(1~{H}-indazol-5-ylmethyl)ethanesulfonamide | 組成式: | C10 H13 N3 O2 S | SMILES: | CC[S](=O)(=O)NCc1ccc2[nH]ncc2c1 | InChi: | InChI=1S/C10H13N3O2S/c1-2-16(14,15)12-6-8-3-4-10-9(5-8)7-11-13-10/h3-5,7,12H,2,6H2,1H3,(H,11,13) | 別名: | N-(1H-indazol-5-ylmethyl)ethenesulfonamide (precursor) | 定義日: | 2022-08-12 | 最終更新日: | 2024-09-27 | 公開日: | 2022-09-28 | 識別子(ID): | ~{N}-(1~{H}-indazol-5-ylmethyl)ethanesulfonamide |
|
 | 55I | 表記: | 4-(trifluoromethyl)-L-phenylalanine | 組成式: | C10 H10 F3 N O2 | SMILES: | FC(F)(F)c1ccc(CC(N)C(=O)O)cc1 | InChi: | InChI=1S/C10H10F3NO2/c11-10(12,13)7-3-1-6(2-4-7)5-8(14)9(15)16/h1-4,8H,5,14H2,(H,15,16)/t8-/m0/s1 | 定義日: | 2021-07-16 | 最終更新日: | 2024-09-27 | 公開日: | 2021-09-29 | 識別子(ID): | 4-(trifluoromethyl)-L-phenylalanine |
|
 | N6Z | 表記: | ~{N}-[3-[6-azanyl-5-[2-[methyl(propanoyl)amino]ethoxy]pyrimidin-4-yl]-5-fluoranyl-2-methyl-phenyl]-4-cyclopropyl-2-fluoranyl-benzamide | 組成式: | C27 H29 F2 N5 O3 | SMILES: | CCC(=O)N(C)CCOc1c(N)ncnc1c2cc(F)cc(NC(=O)c3ccc(cc3F)C4CC4)c2C | InChi: | InChI=1S/C27H29F2N5O3/c1-4-23(35)34(3)9-10-37-25-24(31-14-32-26(25)30)20-12-18(28)13-22(15(20)2)33-27(36)19-8-7-17(11-21(19)29)16-5-6-16/h7-8,11-14,16H,4-6,9-10H2,1-3H3,(H,33,36)(H2,30,31,32) | 定義日: | 2019-11-14 | 最終更新日: | 2024-09-27 | 公開日: | 2020-03-04 | 識別子(ID): | ~{N}-[3-[6-azanyl-5-[2-[methyl(propanoyl)amino]ethoxy]pyrimidin-4-yl]-5-fluoranyl-2-methyl-phenyl]-4-cyclopropyl-2-fluoranyl-benzamide |
|
 | N77 | 表記: | 7-(hydroxyamino)-N-(pyridin-3-ylmethyl)-5-(trifluoromethyl)-1,3-benzothiazole-2-carboxamide 3-oxide | 組成式: | C15 H11 F3 N4 O3 S | SMILES: | FC(F)(F)c3cc1c(sc([n+]1[O-])C(=O)NCc2cccnc2)c(c3)NO | InChi: | InChI=1S/C15H11F3N4O3S/c16-15(17,18)9-4-10(21-24)12-11(5-9)22(25)14(26-12)13(23)20-7-8-2-1-3-19-6-8/h1-6,21,24H,7H2,(H,20,23) | 定義日: | 2014-06-03 | 最終更新日: | 2024-09-27 | 公開日: | 2015-10-21 | 識別子(ID): | 7-(hydroxyamino)-N-(pyridin-3-ylmethyl)-5-(trifluoromethyl)-1,3-benzothiazole-2-carboxamide 3-oxide |
|
 | 55S | 表記: | 6-(cyclohexylmethoxy)-N-[4-(ethylsulfonyl)phenyl]-9H-purin-2-amine | 組成式: | C20 H25 N5 O3 S | SMILES: | c4c(Nc3nc1ncnc1c(OCC2CCCCC2)n3)ccc(c4)S(=O)(CC)=O | InChi: | InChI=1S/C20H25N5O3S/c1-2-29(26,27)16-10-8-15(9-11-16)23-20-24-18-17(21-13-22-18)19(25-20)28-12-14-6-4-3-5-7-14/h8-11,13-14H,2-7,12H2,1H3,(H2,21,22,23,24,25) | 定義日: | 2015-07-30 | 最終更新日: | 2024-09-27 | 公開日: | 2015-09-16 | 識別子(ID): | 6-(cyclohexylmethoxy)-N-[4-(ethylsulfonyl)phenyl]-9H-purin-2-amine |
|
 | 562 | 表記: | N~5~-[N-(2-{2-[2-(triaza-1,2-dien-2-ium-1-yl)ethoxy]ethoxy}ethyl)carbamimidoyl]-L-ornithine | 組成式: | C12 H26 N7 O4 | SMILES: | NC(CCCNC(=N)NCCOCCOCCN=[N+]=N)C(=O)O | InChi: | InChI=1S/C12H25N7O4/c13-10(11(20)21)2-1-3-16-12(14)17-4-6-22-8-9-23-7-5-18-19-15/h10,15H,1-9,13H2,(H3-,14,16,17,20,21)/p+1/t10-/m0/s1 | 定義日: | 2015-07-31 | 最終更新日: | 2024-09-27 | 公開日: | 2018-03-14 | 識別子(ID): | N~5~-[N-(2-{2-[2-(triaza-1,2-dien-2-ium-1-yl)ethoxy]ethoxy}ethyl)carbamimidoyl]-L-ornithine |
|
 | N7P | 表記: | 1-ACETYL-L-PROLINE | 組成式: | C7 H11 N O3 | SMILES: | OC(=O)C1N(C(=O)C)CCC1 | InChi: | InChI=1S/C7H11NO3/c1-5(9)8-4-2-3-6(8)7(10)11/h6H,2-4H2,1H3,(H,10,11)/t6-/m0/s1 | 別名: | N-ACETYLPROLINE | 定義日: | 2003-02-21 | 最終更新日: | 2024-09-27 | 識別子(ID): | 1-acetyl-L-proline |
|